Erythropoietin as an antiapoptotic, tissue-protective cytokine

[1]  R. Heumann,et al.  Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity , 2004, Neurobiology of Disease.

[2]  David W. Johnson,et al.  Erythropoietin protects against ischaemic acute renal injury. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  K. Miskowiak,et al.  Erythropoietin improves place learning in fimbria–fornix-transected rats and modifies the search pattern of normal rats , 2004, Pharmacology Biochemistry and Behavior.

[4]  P. Ghezzi,et al.  Erythropoietin both protects from and reverses experimental diabetic neuropathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Spencer,et al.  Increased Expression of Erythropoietin Receptor on Blood Vessels in the Human Epileptogenic Hippocampus with Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[6]  Katharina D'Herde,et al.  Correction for Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production , 2003, Molecular biology of the cell.

[7]  R. Myers,et al.  ISSLS Prize Winner: Erythropoietin Inhibits Spinal Neuronal Apoptosis and Pain Following Nerve Root Crush , 2003, Spine.

[8]  F. Baron,et al.  Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  G. Gores,et al.  Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression , 2003, Hepatology.

[10]  S. Vilaró,et al.  Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability , 2003, The European journal of neuroscience.

[11]  E. Lakatta,et al.  Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Johnston,et al.  Protective effect of erythropoietin in neonatal hypoxic ischemia in mice , 2003, Neuroreport.

[13]  P. Ghezzi,et al.  Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis , 2003, The Journal of experimental medicine.

[14]  Chul-woo Yang,et al.  Preconditioning with erythropoietin protects against subsequent ischemia‐reperfusion injury in rat kidney , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  R. Myers,et al.  Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury , 2003, The European journal of neuroscience.

[16]  R. Gold,et al.  Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon‐beta , 2003, Glia.

[17]  G. Semenza,et al.  Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.

[18]  W. Buurman,et al.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. , 2003, The American journal of pathology.

[19]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[20]  Z. Erbayraktar,et al.  Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ç. Ulukuş,et al.  Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, Neonatology.

[22]  Pietro Ghezzi,et al.  Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Maiese,et al.  Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways , 2003, British journal of pharmacology.

[24]  M. A. Ajmone-Cat,et al.  Apoptotic PC12 Cells Exposing Phosphatidylserine Promote the Production of Anti‐Inflammatory and Neuroprotective Molecules by Microglial Cells , 2003, Journal of neuropathology and experimental neurology.

[25]  A. Saray,et al.  Effect of Chronic and Short‐Term Erythropoietin Treatment on Random Flap Survival in Rats: An Experimental Study , 2003, The Laryngoscope.

[26]  Kenneth Maiese,et al.  Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases , 2002, Circulation.

[27]  M. Sugawa,et al.  Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation , 2002, Neuroscience Research.

[28]  U. Dirnagl,et al.  Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.

[29]  P. Ghezzi,et al.  Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis , 2002, Brain Research.

[30]  V. Vainionpää,et al.  Potential neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest. , 2002, Journal of Thoracic and Cardiovascular Surgery.

[31]  Satoru Takahashi,et al.  Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. , 2002, Blood.

[32]  K. Kuck,et al.  Erythropoietin and VEGF exhibit equal angiogenic potential. , 2002, Microvascular research.

[33]  P. Lewczuk,et al.  Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.

[34]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  D. Rosenbaum,et al.  Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Bittner,et al.  Erythropoietin induces changes in gene expression in PC-12 cells. , 2002, Brain research. Molecular brain research.

[37]  A. Cerami,et al.  Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Maiese,et al.  Hematopoietic Factor Erythropoietin Fosters Neuroprotection through Novel Signal Transduction Cascades , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  R. Hata,et al.  Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up‐regulating Bcl‐xL expression , 2002, Journal of neuroscience research.

[40]  F. Kuralay,et al.  Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro , 2002, Neuroscience Letters.

[41]  N. Sang,et al.  Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.

[42]  A. Cerami,et al.  Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Flanders,et al.  Erythropoietin receptor signalling is required for normal brain development. , 2002, Development.

[44]  M. Yalaz,et al.  Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. , 2001, Acta medica Okayama.

[45]  Kazuki Sato,et al.  Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia* , 2001, The Journal of Biological Chemistry.

[46]  S. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[47]  V. Fadok,et al.  The phosphatidylserine receptor: a crucial molecular switch? , 2001, Nature Reviews Molecular Cell Biology.

[48]  K. Kurosaka,et al.  Production of proinflammatory cytokines by resident tissue macrophages after phagocytosis of apoptotic cells. , 2001, Cellular immunology.

[49]  M. Akisu,et al.  The Role of Recombinant Human Erythropoietin in Lipid Peroxidation and Platelet-Activating Factor Generation in a Rat Model of Necrotizing Enterocolitis , 2001, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[50]  C. Bagnis,et al.  Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[52]  G. Semenza.  HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.

[53]  Hyun B Choi,et al.  Erythropoietin and Erythropoietin Receptors in Human CNS Neurons, Astrocytes, Microglia, and Oligodendrocytes Grown in Culture , 2001, Journal of neuropathology and experimental neurology.

[54]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  G. Grasso,et al.  Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. , 2001, Journal of neurosurgical sciences.

[56]  W. Brück,et al.  Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain , 2001, Acta Neuropathologica.

[57]  F. Kuralay,et al.  Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production , 2001, Neuroscience Letters.

[58]  M. Kawakami,et al.  Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells. , 2000, Biochemical and biophysical research communications.

[59]  L. Hennighausen,et al.  Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.

[60]  P Ghezzi,et al.  Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Greenberg,et al.  Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity , 2000, Neuroscience Letters.

[62]  K. Ozawa,et al.  A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. , 2000, Blood.

[63]  E. Clementi,et al.  Inhibition of Caspase-1-Like Activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl Ketone Induces Long-Lasting Neuroprotection in Cerebral Ischemia through Apoptosis Reduction and Decrease of Proinflammatory Cytokines , 2000, The Journal of Neuroscience.

[64]  R. Gregory,et al.  Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.

[65]  D. Wojchowski,et al.  A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. , 1999, Blood.

[66]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[67]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[68]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[69]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[70]  K. Koshimura,et al.  Effects of Erythropoietin on Neuronal Activity , 1999, Journal of neurochemistry.

[71]  E. Mackenzie,et al.  A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  A. Mathieu,et al.  Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells , 1999, Cell Death and Differentiation.

[73]  A. Rojiani,et al.  Immunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain , 1999, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[74]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[75]  E. Corsini,et al.  Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. , 1998, Toxicology and applied pharmacology.

[76]  E. Morishita,et al.  In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  A. Devitt,et al.  Human CD14 mediates recognition and phagocytosis of apoptotic cells , 1998, Nature.

[78]  J. Savill.  Apoptosis: Phagocytic docking without shocking , 1998, Nature.

[79]  E. Morishita,et al.  Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death , 1996, Neuroscience.

[80]  G. Núñez,et al.  Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2 , 1996 .

[81]  S. Masuda,et al.  Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. , 1993, The Journal of biological chemistry.

[82]  G. van Zant,et al.  Apoptosis and hematopoiesis in murine fetal liver. , 1993, Blood.

[83]  S. Hobbs,et al.  Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. , 1992, Blood.

[84]  J. Spivak,et al.  Erythropoietin is both a mitogen and a survival factor. , 1991, Blood.

[85]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[87]  J. Bazan.  A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. , 1989, Biochemical and biophysical research communications.

[88]  M. Koury,et al.  Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells , 1988, Journal of cellular physiology.

[89]  P. Falkai,et al.  Erythropoietin: a candidate compound for neuroprotection in schizophrenia , 2004, Molecular Psychiatry.

[90]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.

[91]  C. Sansotta,et al.  Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. , 2002, Acta dermato-venereologica.

[92]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[93]  P. Nicotera,et al.  Organotin compounds induce calcium overload and apoptosis in PC12 cells. , 1995, Neurotoxicology.